S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Infinitus Launches AI Agents to Scale Pharmaceutical Field Operations

Pharmaceutical companies face a stark productivity gap, with sales representatives spending two-thirds of their day on administrative tasks rather than provider engagement. Infinitus is responding to this pressure with FieldForce, a new suite of AI agents designed to handle prep work, follow-ups, and 24/7 provider inquiries without expanding headcount.

Infinitus Launches AI Agents to Scale Pharmaceutical Field Operations
Photo: Bio & News

The platform integrates directly with existing CRM systems to automate meeting preparation and post-visit documentation. By offloading these routine burdens, the technology aims to reclaim time for field teams, allowing representatives and reimbursement managers to focus on high-value interactions. For healthcare providers, the agents act as an always-on resource, providing immediate answers regarding prior authorizations and claims outside of scheduled office visits.

Beyond simple automation, the system enforces strict boundaries between promotional and medical communications. When a provider raises a clinical or safety concern, the agent transfers the inquiry to the medical information team, ensuring compliance while maintaining context. CEO Ankit Jain notes that this AI-first approach has become a competitive necessity as firms grapple with industry-wide workforce reductions and the need for greater efficiency. Backed by a knowledge graph derived from millions of payor interactions, the tool also provides pharmaceutical leaders with granular metrics on provider coverage and the effectiveness of their commercial outreach.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!